Fundraising Fox

ORIC Pharmaceuticals

NASDAQ: ORIC

South San Francisco, US · Delaware corporation · 4 known investors

oricpharma.com ↗

ORIC Pharmaceuticals is a clinical-stage oncology company founded in 2014 to develop cancer therapies that address treatment resistance, with the aim of extending the effectiveness of existing therapies. It has advanced multiple programs into clinical trials for patients with cancer.

BiotechHealthtechin /oric-pharmaceuticals-inc

Founders & leadership

SL
Steve L. HoerterDirector
LK
Lori KunkelDirector
JM
Jacob M. ChackoExecutive Officer, Director
RH
Richard HeymanChairman, Founder, Scientific Advisory Board
DP
Dominic PiscitelliChief Financial Officer
AY
Angie YouDirector
PM
Pratik MultaniChief Medical Officer
MC
Mardi C. DierDirector
MD
Mardi DierDirector
CS
Charles SawyersFounder, Scientific Advisory Board
SL
Scott LoweFounder, Scientific Advisory Board
JC
Jacob ChackoPresident, Chief Executive Officer and Board Member

Investors · 4

EcoR1 CapitalSan Francisco
Nextech InvestZurich · $648K – $3.2M
Taiho Ventures, LLCMenlo Park
The Column GroupSan Francisco · $30M

Reported raises · per SEC filings

Form D private placements
▶$125MraisedJun 2025 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Steve L. HoerterDirector
  • Lori KunkelDirector
  • Jacob M. ChackoExecutive Officer, Director
  • Richard HeymanDirector
  • Dominic PiscitelliExecutive Officer
  • Angie YouDirector
  • Pratik MultaniExecutive Officer
  • Mardi C. DierDirector
Offering amount
$125M
Amount sold
$125M
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$125MraisedJan 2024 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Angie YouDirector
  • Lori KunkelDirector
  • Steve L. HoerterDirector
  • Dominic PiscitelliExecutive Officer
  • Jacob M. ChackoExecutive Officer, Director
  • Richard HeymanDirector
  • Mardi DierDirector
  • Pratik MultaniExecutive Officer
Offering amount
$125M
Amount sold
$125M
First sale
Jan 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedJul 2023 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Angie YouDirector
  • Richard HeymanDirector
  • Steve L. HoerterDirector
  • Jacob M. ChackoExecutive Officer, Director
  • Mardi DierDirector
  • Lori KunkelDirector
  • Dominic PiscitelliExecutive Officer
  • Pratik MultaniExecutive Officer
Offering amount
$85M
Amount sold
$85M
First sale
Jun 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.